Physician profile
Benjamin Walker Appelo
NPI 1063909158
$1,629.75
in general payments reported to CMS, 2019-2025
11 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $222 · 2023: $443 · 2024: $444 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.96 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $360.80 | 2022-2025 | Durysta |
| Biotissue Holdings INC. | $331.14 | 2021-2023 | |
| Ocular Therapeutix, INC. | $187.72 | 2022-2025 | Dextenza |
| Alcon Vision LLC | $154.50 | 2023-2025 | Clareon, Unity, Centurion |
| Rxsight INC | $142.81 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Allergan, INC. | $126.86 | 2021 | |
| Mallinckrodt Hospital Products INC. | $124.22 | 2024 | Acthar |
| Bausch & Lomb Americas INC. | $108.95 | 2022 | |
| Glaukos Corporation | $40.38 | 2023 | |
| Dompe US, INC. | $31.60 | 2025 | Oxervate |
| Astellas Pharma US INC | $20.77 | 2025 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Appelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.